Australia appears to be experience potentially transformative medication for excess weight: Retatrutide. This new dual molecule – acting on both GLP-1 and GIP receptors – demonstrates promising outcomes in clinical studies, suggesting meaningful reductions in BMI. While availability hasn't occurr